Illinois Municipal Retirement Fund Sells 12,915 Shares of Kenvue Inc. (NYSE:KVUE)

Illinois Municipal Retirement Fund lessened its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 3.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 352,519 shares of the company's stock after selling 12,915 shares during the quarter. Illinois Municipal Retirement Fund's holdings in Kenvue were worth $8,453,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of KVUE. LaFleur & Godfrey LLC raised its holdings in shares of Kenvue by 29.8% during the 4th quarter. LaFleur & Godfrey LLC now owns 81,300 shares of the company's stock valued at $1,736,000 after buying an additional 18,650 shares in the last quarter. Atria Wealth Solutions Inc. raised its holdings in shares of Kenvue by 106.9% during the 4th quarter. Atria Wealth Solutions Inc. now owns 18,257 shares of the company's stock valued at $390,000 after buying an additional 9,432 shares in the last quarter. Private Advisor Group LLC raised its holdings in shares of Kenvue by 34.1% during the 4th quarter. Private Advisor Group LLC now owns 50,076 shares of the company's stock valued at $1,069,000 after buying an additional 12,729 shares in the last quarter. Ieq Capital LLC raised its holdings in shares of Kenvue by 20.0% during the 4th quarter. Ieq Capital LLC now owns 12,853 shares of the company's stock valued at $274,000 after buying an additional 2,146 shares in the last quarter. Finally, IFP Advisors Inc raised its holdings in shares of Kenvue by 168.4% during the 4th quarter. IFP Advisors Inc now owns 12,197 shares of the company's stock valued at $263,000 after buying an additional 7,652 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

KVUE has been the subject of several recent research reports. Redburn Atlantic initiated coverage on Kenvue in a research report on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price objective for the company. Citigroup reiterated a "neutral" rating on shares of Kenvue in a research report on Friday, June 13th. Barclays boosted their price objective on Kenvue from $22.00 to $23.00 and gave the company an "equal weight" rating in a research report on Monday, May 12th. Canaccord Genuity Group boosted their price objective on Kenvue from $24.00 to $29.00 and gave the company a "buy" rating in a research report on Wednesday, March 5th. Finally, UBS Group boosted their price objective on Kenvue from $24.00 to $25.00 and gave the company a "neutral" rating in a research report on Friday, May 9th. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, Kenvue currently has a consensus rating of "Hold" and an average target price of $25.33.

Kenvue Price Performance

Shares of Kenvue stock opened at $20.89 on Friday. The company has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio of 0.63. The company has a market cap of $40.07 billion, a PE ratio of 37.97, a P/E/G ratio of 3.28 and a beta of 0.98. The business has a 50 day moving average of $22.85 and a 200 day moving average of $22.37. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.24 EPS for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. The company had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. The firm's revenue for the quarter was down 3.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.28 earnings per share. As a group, equities research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th were issued a dividend of $0.205 per share. The ex-dividend date was Wednesday, May 14th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.93%. Kenvue's dividend payout ratio is presently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.